BackClarim Acquisition - Warrants (05/01/2026) Overview

Clarim Acquisition - Warrants (05/01/2026) Other Current Liabilities

Clarim Acquisition - Warrants (05/01/2026)'s other current liabilities is $1M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$998451.00
135.45% YoYΔ $574383.00 vs prior year quarter

Peer trimmed avg / median

Loading

Clarim Acquisition - Warrants (05/01/2026) Other Current Liabilities History

Loading

Clarim Acquisition - Warrants (05/01/2026) vs. peers: Other Current Liabilities Comparison

Loading

Clarim Acquisition - Warrants (05/01/2026) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clarim Acquisition - Warrants (05/01/2026) (CLRMW) FAQ

As of the most recent data (September 2022), CLRMW shows a other current liabilities of $1M. That compares with $420K in the prior-year period — up 135.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLRMW's other current liabilities is now $1M (was $420K) — a 135.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clarim Acquisition - Warrants (05/01/2026) is outperforming or lagging.

Tracking CLRMW's other current liabilities over time shows whether Clarim Acquisition - Warrants (05/01/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $1M That compares with $420K in the prior-year period — up 135.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Clarim Acquisition - Warrants (05/01/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1M) with ownership activity and broader fundamentals.